Efficacy and Safety of Voriconazole Prophylaxis in Pedeatric Patients with Acute Myeloid Leukemia in Egypt

被引：0
|
作者：
Madney, Y. [1 ,2 ]
Arafah, O. [1 ,2 ]
Hafez, H. [1 ,2 ]
Shalaby, L. [1 ,2 ]
Zaki, I. [1 ,2 ]
El-Mahalawy, H. [2 ]
机构：
[1] Children Canc Hosp Egypt, Pediat Oncol, Cairo, Egypt
[2] Natl Canc Inst, Pediat Oncol, Cairo, Egypt
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-436
引用
收藏
页码：S365 / S366
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia
    Machherndl-Spandl, Sigrid
    Vockenhuber, Thomas
    Binder, Michaela
    Weltermann, Ansgar
    Apfalter, Petra
    Lass-Floerl, Cornelia
    Girschikofsky, Michael
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2330 - 2335
  • [2] Safety and efficacy of primary prophylaxis with voriconazole in adult patients with acute leukemia
    Tomas, Jose F.
    Delgado, Pilar
    Garcia-Zueco, Juan C.
    de Ona, Raquel
    Estevez, Monica
    Rezusta, A.
    Yague, D.
    Garcia-Cia, Jose I.
    Iglesias, Rebeca
    Rubio-Felix, Daniel
    BLOOD, 2007, 110 (11) : 161B - 161B
  • [3] Efficacy and safety of Voriconazole as first-line IFI-prophylaxis in patients with acute myeloid leukemia - A single centre experience
    Vockenhuber, T.
    Weltermann, A.
    Binder, M.
    Machherndl-Spandl, S.
    Girschikofsky, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 58 - 59
  • [4] Comparable Efficacy and Safety with Voriconazole or Posaconazole as Primary Antifungal Prophylaxis in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy
    Wetzstein, Gene A.
    George, Timothy J.
    Sharifi, Mahsa
    Hoang, Van D.
    Ho, Viet Q.
    Quilitz, Rod E.
    Spears, Dana A.
    Komrokji, Rami S.
    List, Alan F.
    Lancet, Jeffrey E.
    Greene, John N.
    BLOOD, 2009, 114 (22) : 813 - 813
  • [5] Toxicity and Efficacy of Isavuconazole Vs Voriconazole As Anti-Fungal Prophylaxis for Patients with Acute Myeloid Leukemia
    Hunter, Cameron J.
    Bewersdorf, Jan Philipp
    Mendez, Lourdes
    Podoltsev, Nikolai A.
    Zeidan, Amer M.
    Eighmy, William
    Roeder, Heidi
    Malinis, Maricar
    Shallis, Rory M.
    BLOOD, 2024, 144 : 1480 - 1481
  • [6] PRIMARY PROPHYLAXIS WITH VORICONAZOLE IN ADULTS PATIENTS WITH ACUTE MYELOID LEUKEMIA: 37 CASES
    Delgado Beltran, P.
    Garcia-Zueco, J.
    Costilla Barriga, L.
    Rubio-Felix, D.
    HAEMATOLOGICA, 2012, 97 : 573 - 573
  • [7] Efficacy and safety of thalidomide in patients with acute myeloid leukemia
    Steins, MB
    Padró, T
    Bieker, R
    Ruiz, S
    Kropff, M
    Kienast, J
    Kessler, T
    Buechner, T
    Berdel, WE
    Mesters, RM
    BLOOD, 2002, 99 (03) : 834 - 839
  • [8] Comparison of Posaconazole Versus Voriconazole in the Induction of Acute Myeloid Leukemia: Impact on Cost, Safety, and Efficacy
    Antosz, Olivia
    Peyton-Thomas, Breanne
    Selby, Christopher
    Bozeman, Amy
    Leary, Cheri
    Devarakonda, Srinivas
    Mansour, Richard
    Mills, Glenn
    Koshy, Nebu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S345 - S345
  • [9] Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
    Gloria N. Mattiuzzi
    Jorge Cortes
    Gladys Alvarado
    Srdan Verstovsek
    Charles Koller
    Sherry Pierce
    Deborah Blamble
    Stefan Faderl
    Lianchun Xiao
    Mike Hernandez
    Hagop Kantarjian
    Supportive Care in Cancer, 2011, 19 : 19 - 26
  • [10] Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome
    Mattiuzzi, Gloria N.
    Cortes, Jorge
    Alvarado, Gladys
    Verstovsek, Srdan
    Koller, Charles
    Pierce, Sherry
    Blamble, Deborah
    Faderl, Stefan
    Xiao, Lianchun
    Hernandez, Mike
    Kantarjian, Hagop
    SUPPORTIVE CARE IN CANCER, 2011, 19 (01) : 19 - 26
12345